In this episode of Skincare Confidential, Dr. Ted Lain interviews Dr. Mark Lupin about the innovative skincare product P-TIOX and its clinical trial results. They discuss the unique formulation of P-TIOX, its mechanism of action, and the findings from a double-blind randomized controlled study that evaluated its efficacy in improving skin quality and appearance. The conversation also touches on the future of aesthetic dermatology, including advancements in laser technology and regenerative medicine

A big thanks to our sponsor Skinceuticals.

Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

See omnystudio.com/listener for privacy information.

In this episode of Skincare Confidential, Dr. Patti Farris and Dr. Zoe Draelos discuss the impact of Advanced Glycation End Products (AGEs) on skin aging and health. They explore how AGEs form, their effects on skin elasticity and healing, and the importance of diet and skincare in managing their accumulation.  The recently reformulated Skinceuticals A.G.E. Interruptor is a modernized formulation that delivers a multimodal approach to target the glycation process. Dr. Draelos shares insights from her research on A.G.E Interrupter Advanced and its effectiveness when used in combination with radiofrequency microneedling. 

A big thanks to our sponsor Skinceuticals.

Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

See omnystudio.com/listener for privacy information.

In this episode of Skincare Confidential, Dr. Ted Lain interviews Dr. Jihee Kim about her groundbreaking research on the combination of microneedling and antioxidants, specifically CE-Ferulic. They discuss the methodology, results, and implications of her studies, which demonstrate significant improvements in skin elasticity and rejuvenation. The conversation also touches on best practices for home microneedling, the importance of understanding cultural differences in dermatology, and the future of integrated skincare.

A big thanks to our sponsor Skinceuticals.

Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

See omnystudio.com/listener for privacy information.

Dr Lain reviews the latest publications and FDA findings with our expert panel including Tom Re, a toxicologist, and Peter Foltis, a formulator.  Building on our first episode on this subject, we again strive to put this into perspective for practicing clinicians and consumers alike.  

Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

See omnystudio.com/listener for privacy information.

In this episode of Skincare Confidential, Dr. Patti Farris and Dr. Ellen Gendler discuss the resurgence of topical estrogen in skincare. In this engaging conversation, Ellen Gendler shares her years of experience and knowledge surrounding the use of topical estrogen creams. They explore the complexities of intrinsic aging, the clinical signs of estrogen deficient skin and the role of topical estrogen for preventing skin aging. They also discuss some of the concerns surrounding the use of topical estrogen and the potential role for selective estrogen receptor modulators or SERMs.

 

Takeaways

Topical estrogens have gained popularity for their potential skin benefits.
Estrogen deficiency leads to various skin issues as we age.
Topical estrogen can be beneficial when used correctly and in moderation.
Concerns about systemic absorption of topical estrogens are prevalent.
Case reports should be interpreted cautiously in the context of topical estrogen use.
Different types of estrogens have varying effects on the skin.
Studies show that topical estrogens can improve skin thickness and elasticity.
Topical estrogens are not a substitute for other effective skincare treatments. Topical estrogen is more about prevention than reversal.
Visible changes in skin care treatments are often immediate, unlike estrogen.
The effectiveness of topical estrogen varies between sun-protected and photodamaged skin.
Retinoids remain the gold standard in skin care for aging.
Melasma exacerbation is a concern with topical estrogen, but evidence is limited.
SERM compounds show promise but require more research.
Combination approaches in skin care yield better results than relying on a single product.
Online health products are proliferating, but caution is necessary.
The importance of vetting sources for topical treatments cannot be overstated.
Clinical judgment is essential in evaluating the effectiveness of skin care treatments.

Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

See omnystudio.com/listener for privacy information.

In this episode of Skincare Confidential, Dr. Ted Lain and Dr. Patti Farris discuss the latest innovations in skincare from the AAD meeting in Orlando. They explore emerging brands, new ingredients like Thiamidol, the impact of GLP-1 agonists on skin health, and the growing interest in nutraceuticals. The conversation also covers advancements in cleansing technology, the importance of addressing pre-aging and menopausal skin, and the future of growth factors and exosomes in skincare.

Be sure to visit our YouTube page for more great content: https://www.youtube.com/@skincareconfidentialpodcast

Takeaways:

Thiamidol is a promising new ingredient for skin lightening.
Hydroquinone alternatives are essential for patient safety.
GLP-1 agonists are being formulated into skincare products to address skin laxity.
Nutraceuticals are gaining traction as a holistic approach to skincare.
Cleansing technology is evolving to leave beneficial ingredients on the skin.
Pre-aging products are being developed for younger demographics.
Menopausal skin care is becoming a focal point for many brands.
Growth factors and exosomes are at the forefront of skincare innovation.
Companies are increasingly backing their products with clinical data.

Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

 

See omnystudio.com/listener for privacy information.

In this episode of Skincare Confidential, Dr. Ted Lain interviews Dr. Michael Gold, a leading expert in dermal fillers and aesthetic medicine. They discuss the evolution of dermal fillers, including the latest innovations in adipose-derived fillers and biostimulatory products. Dr. Gold shares insights on the regulatory landscape for fillers in the US compared to other countries, the importance of skin quality in aesthetic treatments, and the future of regenerative medicine in dermatology. The conversation highlights the growing market for fillers and the exciting developments on the horizon.

Takeaways:

Dr. Gold has been instrumental in the growth of aesthetic conferences.
The US has a limited number of fillers compared to Europe and Asia.
Renuva is a unique adipose-derived filler with regenerative properties.
Sculptra is a biostimulatory filler that promotes collagen production.
Emerging fillers are being developed with innovative combinations of ingredients.
Skin quality is becoming a key focus in filler treatments.
PDRN shows promise for regenerative skin treatments but is limited in the US.
Regulatory hurdles impact the availability of new fillers in the US market.
The future of fillers looks promising with many new products on the horizon.
Education and clinical trials are essential for the safe use of fillers.

Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

See omnystudio.com/listener for privacy information.

In this episode of Skincare Confidential, Dr. Ted Lain interviews Dr. Mark Nestor, a leading expert in neurotoxins, particularly Botox. They discuss the mechanisms of action of neurotoxins, the importance of molecular potency, and the various medical and cosmetic applications of these substances. The conversation also touches on emerging toxins, the impact of neurotoxins on skin quality and mental health, and innovations in toxin delivery methods. Dr. Nestor emphasizes the need for a nuanced understanding of neurotoxins and their effects on patients, as well as the exciting future developments in this field.

Disclaimer: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

 

See omnystudio.com/listener for privacy information.

In this episode of Skincare Confidential, Dr. Patti Farris interviews Keith O'Briant, CEO and founder of Hydrinity, discussing the innovative approaches to skincare rooted in science and regenerative medicine. They explore the unique properties of hyaluronic acid, the importance of peptides and antioxidants, and the rapid expansion of Hydrinity's product line, which emphasizes effective, science-backed formulations. Keith shares insights into the company's philosophy of combining luxury with scientific efficacy, and the future direction of Hydrinity's offerings.

Be sure to check out our YouTube page to see all of these conversations:  https://www.youtube.com/@skincareconfidentialpodcast

Takeaways

The Science of Skincare Summit was a great success.

Hydrinity was born out of a regenerative medicine company.

Hyaluronic acid is underutilized in skincare.

Hydrinity uses a unique extraction method for HA.

The company focuses on dual molecular weight HA for better results.

Peptides play a crucial role in Hydrinity's formulations.

The restorative serum is ideal for post-procedure care.

Vivid Brightening targets pigmentation without hydroquinone.

Hydrinity has expanded to 22 countries in just two years.

The future of Hydrinity includes innovative products not seen before.

DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

See omnystudio.com/listener for privacy information.

In this episode of Skincare Confidential, Dr. Ted Lain interviews Carl D'Ruiz, a key figure in the skincare industry, about the introduction of a new sunscreen filter, Bemotrizinol (Parsol® Shield), to the U.S. market. They discuss the long-standing regulatory challenges that have hindered the approval of new UV filters, the implications for public health, and the role of DSM in innovating skincare solutions. The conversation highlights the importance of transparency in ingredient safety and the need for updated regulations to keep pace with global standards. Carl shares insights into DSM's commitment to public health and the future of sunscreen filters in the U.S.

 

Be sure to check out our YouTube page to see all of these conversations:  https://www.youtube.com/@skincareconfidentialpodcast

Takeaways

A new UV filter has not been introduced in the U.S. for 26 years.

The FDA's regulations for sunscreen are complex and outdated.

Public health is at risk due to limited sunscreen options.

DSM is leading the way in bringing new filters to market.

Bemotrizinol (Parsol® Shield)has a long history of safe use in Europe.

Consumer preferences impact sunscreen usage and public health.

Transparency in ingredient safety is crucial for consumer trust.

New regulations are being implemented to improve safety standards.

The skincare industry is evolving with innovative ingredients.

Collaboration between companies and regulators is essential for progress.

 

DISCLAIMER: This podcast is not intended to provide diagnosis, treatment, or medical advice. Content provided in this podcast is for educational purposes only. Please consult with a physician regarding any health-related diagnosis or treatment.

See omnystudio.com/listener for privacy information.